newsfilter
← Latest News
PR Newswire·

The Special Committee of the Board of Directors of Liminal Biosciences Retains an Independent Financial Advisor in Response to Unsolicited Non-Binding Transaction Proposal

LAVAL, QC and CAMBRIDGE, England, May 8, 2023 /CNW/ - Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), re-confirms that the board of directors of the Company has already